RE: Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer. Orlandi A. J Natl Cancer Inst 2025 Nov 5:djaf319. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Orlandi A. RE: Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer. J Natl Cancer Inst 2025 Nov 5:djaf319. doi: 10.1093.
PMID: 41206135